| 書(shū)目名稱(chēng) | Peritoneal Carcinomatosis: Drugs and Diseases | | 編輯 | Paul H. Sugarbaker | | 視頻video | http://file.papertrans.cn/745/744177/744177.mp4 | | 叢書(shū)名稱(chēng) | Cancer Treatment and Research | | 圖書(shū)封面 |  | | 描述 | Peritoneal carcinomatosis dominates the clinical picture of many patients with gastrointestinal, gynecological and urological cancers. For many of them its dev- astating effects contribute directly to their death. Most clinicians consider peritoneal carcinomatosis an incurable metastatic disease and give palliative treatment, re- stricted to limited surgery and systemic chemotherapy. Contrary to this view, Paul Sugarbaker and his collegues base their approach on the concept that peritoneal carcinomatosis represents regional tumor spread, similar in its impact on treatment and prognosis to that of lymph node metastases in other malignancies. This concept emphasises the value of regional tumor control, as a potentially curative measure. In this book the combination of aggressive cytoreduction and intraperitoneal chemotherapy to control peritoneal carcinomatosis is extensively explored. Basic to this approach is the observation that most cancer cells show only relative resistence against commonly available drugs, which can be overcome by a sufficient increase of drug concentrations in tumor tissue. After intraperitoneal delivery, drugs will reach high tissue concentrations in the supe | | 出版日期 | Book 1996 | | 關(guān)鍵詞 | carcinoma; gastric cancer; immunotherapy; mesothelioma; metastasis; pathology; pharmacology; prevention; sur | | 版次 | 1 | | doi | https://doi.org/10.1007/978-1-4613-1245-1 | | isbn_softcover | 978-1-4612-8530-4 | | isbn_ebook | 978-1-4613-1245-1Series ISSN 0927-3042 Series E-ISSN 2509-8497 | | issn_series | 0927-3042 | | copyright | Kluwer Academic Publishers 1996 |
The information of publication is updating
|
|
|Archiver|手機(jī)版|小黑屋|
派博傳思國(guó)際
( 京公網(wǎng)安備110108008328)
GMT+8, 2025-10-15 22:00
發(fā)表于 2025-3-21 16:16:07
